Topics
- Critical insights into European trends in public health insurance
- How to develop an effective strategy to succeed in country-specific negotiations for price approval and granting of reimbursement
- How to deal with the increasing complexity and uncertainty in current pricing & reimbursement environment
- Best practices in development of pharmco-economic studies
- Market access an integral part of the company
- Cost-effectiveness measures & the impact on the industry – is the innovation rewarded correctly?
- The role of patient organisations and social networks on increase of patient influence
- Incorporating market access into the entire drug’s life cycle
- Future Challenges in Market Access
- SEE trends in pricing and reimbursement
- P&R Country Reports: Turkey, Romania, Bulgaria, Bosnia and Herzegvina and Croatia
- Take a look at payers perspective
Who should Attend
Vice Presidents, Senior Vice Presidents, Global Heads, Senior Executives, Directors, Heads, Managers and Senior Managers responsible for:
- Market Access
- Pricing & Reimbursement
- Health Economics
- Commercial Pricing and Pricing Strategists
- Regulatory Affairs
- Outcomes Research
- Public Affairs
- Governmental Affairs
- Governmental bodies
- Public Policy Directors
- Regulatory bodies
